Jan 29, 2026
Ro Khanna- Amount
- Receipt pending ingestion
- Filed
- Feb 6, 2026
Congress ticker disclosure profile
As of August 1 at 7:12 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference EVRG. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
11
Member filers
5
Disclosed ranges
$24K
Most active member desks
Balanced
Latest trade Jan 29, 2026
Jan 29, 2026
Ro KhannaApr 11, 2025
Dan NewhouseMar 16, 2022
John RutherfordFeb 17, 2022
John RutherfordMay 29, 2020
Ro KhannaApr 7, 2020
Ro KhannaAug 2, 2019
Ro KhannaMar 25, 2019
Nicholas Van TaylorDec 17, 2018
Ro KhannaDec 7, 2018
Ro KhannaJun 5, 2018
Jacky Rosen| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Jan 29, 2026 | Ro Khanna | Buy | Receipt pending ingestion | Feb 6, 2026 | Open card |
| Apr 11, 2025 | Dan Newhouse | Sell | $1,001 to $15,000 | May 16, 2025 | Open card |
| Mar 16, 2022 | John Rutherford | Sell | $1,001 to $15,000 | Apr 19, 2022 | Open card |
| Feb 17, 2022 | John Rutherford | Buy | Receipt pending ingestion | Mar 16, 2022 | Open card |
| May 29, 2020 | Ro Khanna | Buy | Receipt pending ingestion | Oct 21, 2020 | Open card |
| Apr 7, 2020 | Ro Khanna | Sell | Receipt pending ingestion | May 13, 2020 | Open card |
| Aug 2, 2019 | Ro Khanna | Buy | Receipt pending ingestion | Sep 11, 2019 | Open card |
| Mar 25, 2019 | Nicholas Van Taylor | Sell | $1,001 to $15,000 | Apr 15, 2019 | Open card |
| Dec 17, 2018 | Ro Khanna | Sell | Receipt pending ingestion | Jan 11, 2019 | Open card |
| Dec 7, 2018 | Ro Khanna | Buy | Receipt pending ingestion | Jan 11, 2019 | Open card |
| Jun 5, 2018 | Jacky Rosen | Exchange | Receipt pending ingestion | Jul 15, 2018 | Receipt pending ingestion |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 3 of 11 filed rows include disclosed amount ranges (27%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.